BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12786609)

  • 1. Review article: medical treatment of moderate to severe Crohn's disease.
    Scribano M; Prantera C
    Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():23-30. PubMed ID: 12786609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical management of Crohn's disease.
    Cottone M; Renna S; Orlando A; Mocciaro F
    Expert Opin Pharmacother; 2011 Nov; 12(16):2505-25. PubMed ID: 21988215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug safety in Crohn's disease therapy.
    Juillerat P; Pittet V; Felley C; Mottet C; Froehlich F; Vader JP; Gonvers JJ; Michetti P
    Digestion; 2007; 76(2):161-8. PubMed ID: 18239408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: maintenance treatment of Crohn's disease.
    Biancone L; Tosti C; Fina D; Fantini M; De Nigris F; Geremia A; Pallone F
    Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():31-7. PubMed ID: 12786610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of remission in Crohn's disease: current and emerging therapeutic options.
    Brookes MJ; Green JR
    Drugs; 2004; 64(10):1069-89. PubMed ID: 15139787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Crohn's disease--a practical approach.
    Knutson D; Greenberg G; Cronau H
    Am Fam Physician; 2003 Aug; 68(4):707-14. PubMed ID: 12952387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis.
    Hazlewood GS; Rezaie A; Borman M; Panaccione R; Ghosh S; Seow CH; Kuenzig E; Tomlinson G; Siegel CA; Melmed GY; Kaplan GG
    Gastroenterology; 2015 Feb; 148(2):344-54.e5; quiz e14-5. PubMed ID: 25448924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Outcome of Early Combined Immunosuppression Versus Conventional Management in Newly Diagnosed Crohn's Disease.
    Hoekman DR; Stibbe JA; Baert FJ; Caenepeel P; Vergauwe P; De Vos M; Hommes DW; Benninga MA; Vermeire SA; D'Haens GR;
    J Crohns Colitis; 2018 Apr; 12(5):517-524. PubMed ID: 29401297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: medical treatment of active Crohn's disease.
    Scribano ML; Prantera C
    Aliment Pharmacol Ther; 2002 Jul; 16 Suppl 4():35-9. PubMed ID: 12047258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Crohn's disease].
    Vavricka SR; Rogler G
    Praxis (Bern 1994); 2009 Jan; 98(2):77-81. PubMed ID: 19153955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
    Hanauer SB; Stathopoulos G
    Drug Saf; 1991; 6(3):192-219. PubMed ID: 1676590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug treatment of Crohn's disease].
    van Deventer SJ; Tytgat GN
    Ned Tijdschr Geneeskd; 1998 May; 142(21):1191-5. PubMed ID: 9627451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
    Vermeire S; van Assche G; Rutgeerts P
    Aliment Pharmacol Ther; 2007 Jan; 25(1):3-12. PubMed ID: 17229216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild to moderate Crohn's disease: still room for step-up therapies?
    Bar-Meir S
    Dig Dis; 2009; 27(3):347-50. PubMed ID: 19786763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance therapy in Crohn's disease.
    Steinhart H
    Can J Gastroenterol; 2000 Sep; 14 Suppl C():23C-28C. PubMed ID: 11023557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.